It was never your willpower.

When you restrict calories, your body compensates by lowering your metabolic rate and increasing hunger hormones like ghrelin. This is not a character flaw — it's an evolved biological mechanism. GLP-1 medications work at the hormonal level to interrupt this cycle, making sustainable weight loss achievable for the first time.

"Food noise" is the constant mental preoccupation with food — thinking about what to eat next, craving things between meals, feeling like your brain never shuts off around food. GLP-1 medications reduce this dramatically for many patients. The silence is often described as one of the most life-changing effects.

Ozempic and Wegovy both contain semaglutide but differ in approved indications and maximum dosing. Wegovy is approved specifically for chronic weight management at a higher max dose. Mounjaro (tirzepatide) is a dual GIP/GLP-1 agonist that targets two hormonal pathways and has shown higher average weight loss in clinical trials. Crystal matches the right medication to your specific biology and goals.

Yes. Contrave (naltrexone/bupropion) is a daily oral tablet that works on the brain's reward and craving pathways. It's particularly effective for patients whose weight is driven by emotional eating, stress eating, or compulsive food behaviors rather than purely appetite volume. Crystal may recommend it as an alternative or adjunct to injectable GLP-1 medications.

GLP-1 medications (Ozempic, Wegovy, Mounjaro) are self-administered as a subcutaneous injection once per week using a small prefilled pen device. The needle is very fine and most patients describe it as nearly painless. Crystal walks you through the injection technique at your first appointment. Contrave is taken as an oral tablet twice daily.

Titration means starting at a low dose and gradually increasing it over several weeks to minimize side effects while maximizing efficacy. Crystal manages your titration schedule personally — she doesn't just hand you a pen and leave you to figure it out. Dosing is adjusted based on how you respond, not a rigid calendar.

Crystal prescribes in 90-day cycles, so you see her quarterly for a full bloodwork review, progress assessment, and protocol adjustment. Between appointments, Ava (our AI concierge) is available 24/7 for any questions or concerns, and can escalate clinical questions to Crystal when needed.

Thyroid function is part of Crystal's comprehensive bloodwork panel. GLP-1 medications are contraindicated in patients with a personal or family history of medullary thyroid carcinoma or MEN2 syndrome. Crystal reviews your full history and bloodwork before prescribing and will discuss any contraindications with you at your consultation.

No. GLP-1 receptor agonists have been studied for over 20 years and have extensive clinical trial data behind them. They are Health Canada-approved medications prescribed by licensed clinicians. This is not a supplement or a program — it is evidence-based pharmacological treatment for a chronic metabolic condition.

Yes — we offer a couples discount when both partners enroll. Ask Brett about it during your free consultation. It's a meaningful saving and many couples find that shared accountability significantly improves outcomes for both.

The most common reason GLP-1 medications fail is inadequate titration, underlying metabolic issues that weren't identified, or stopping too early due to side effects that were manageable with proper guidance. Crystal's comprehensive bloodwork often uncovers issues like insulin resistance or thyroid dysfunction that explain why previous attempts didn't work — and change the approach accordingly.

Memberships start from $125/month and include your clinical care, bloodwork requisitions, ongoing monitoring, and protocol adjustments. Medication cost is separate and varies by which GLP-1 is prescribed, but is often partially or fully covered by workplace insurance. Brett walks you through the full cost breakdown during your free consultation.

Yes — significantly. Weight loss improves insulin sensitivity, reduces inflammation, lowers cortisol, and often restores sex hormone levels (testosterone in men, estrogen balance in women). It can reverse or reduce hormonal issues that were being driven by excess adipose tissue. Many patients also experience improvements in libido, energy, and mood as a direct result. Crystal monitors all of this.

Eligibility is based on clinical assessment, not a number on a scale. Crystal evaluates your BMI, metabolic markers, symptoms, and health history together. Patients are eligible if they have a BMI ≥27 with at least one weight-related comorbidity, or BMI ≥30. She will confirm this at your initial consultation.

Clinical trial averages range from 15% body weight loss with semaglutide to 20–25% with tirzepatide (Mounjaro). Individual results vary based on your starting point, adherence, diet, activity, and underlying metabolic health. Tier1 Optimal does not guarantee specific outcomes.

Most patients notice a reduction in appetite and food noise within the first 1–2 weeks. Measurable weight loss typically begins by weeks 3–6. Significant visual changes are common by the 90-day mark. The pace depends on your dose, titration schedule, and adherence.

Crystal orders a comprehensive metabolic panel that includes: fasting insulin and glucose (for insulin resistance), HbA1c, full thyroid panel (TSH, free T3, free T4), cortisol, lipid panel, liver enzymes, kidney function, CBC, and sex hormone levels. This is far more thorough than the basic panels most family doctors run.

GLP-1 medications are Health Canada-approved and have 15+ years of clinical safety data. Common side effects during titration include nausea, constipation, and fatigue — most of which resolve with proper dosing management. Crystal screens for contraindications (including thyroid history, pancreatitis history, and kidney function) before prescribing and monitors your safety throughout.

Studies show that many patients regain weight after stopping GLP-1 medications, because obesity is a chronic condition. This is why Crystal treats it as long-term care, not a short-term fix. Some patients are able to taper off successfully after reaching their goal weight and establishing new metabolic patterns — Crystal guides this process based on your individual data.

Medication coverage varies significantly. Many workplace group insurance plans cover GLP-1 medications, sometimes up to 100%, particularly when prescribed for weight management with supporting clinical documentation. Brett helps every patient check their coverage and navigate the prior authorization process where required.

Exercise is not required for the medication to work, but it significantly improves outcomes — particularly for preserving lean muscle mass during weight loss. Crystal may make recommendations based on your health status and goals. Many patients find that increased energy from the medication makes it easier to add movement naturally.

Yes — improving insulin sensitivity is one of the primary mechanisms of GLP-1 medications. For patients with insulin resistance (which often goes undiagnosed), this can be transformative: not just for weight loss, but for energy levels, mental clarity, and long-term metabolic health.

Not necessarily, but it depends on your individual biology and goals. Many patients benefit from long-term use as maintenance. Others taper off after reaching their target and establishing new eating patterns. Crystal makes this decision with you based on your data — not a blanket policy.

Yes — and this combination is often highly synergistic. TRT in men and HRT in women can improve body composition, preserve muscle mass during weight loss, and enhance overall energy and wellbeing. Crystal manages all of this within a single protocol, which is one of the key advantages of working with a single dedicated clinician.

No referral required. Crystal is a Nurse Practitioner with autonomous prescribing authority in Ontario. You book directly, complete your intake forms, and see Crystal for your first clinical appointment — no family doctor involved unless you want them to be.

Crystal reviews your full bloodwork panel, assesses your progress, adjusts your protocol if needed, and issues your next 90-day prescription. Your medication supply is coordinated to ship before you run out. Ava handles all the scheduling and administrative coordination so you don't have to think about it.

Partially yes. GLP-1 medications reduce the reward response to food and quiet food cravings, which helps. Contrave works more directly on the brain's reward pathways and is particularly useful for emotional eating patterns. Crystal evaluates your specific situation and recommends the most appropriate medication. In some cases, she may suggest complementary support as well.

Medication is dispensed by a licensed pharmacy and mailed discreetly to your door — including controlled substances where applicable. Crystal sends the prescription directly to the pharmacy, and Ava coordinates the dispatch timing to ensure you receive your supply before you need it.

Book a free consultation with Brett below — no credit card required. He'll walk you through the plans, pricing, insurance options, and what your first 90 days look like. If you're ready to start clinical care right away, you can also book directly with Crystal through our EHR system.